KRAS Wild-type Metastatic Colorectal Cancer Trial

NCT00879385 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Dacogen™ (decitabine)
DRUG: Vectibix® (panitumumab)

Sponsor

University of Utah

Collaborators

[object Object]
[object Object]